N-bromobutanimide → HCID 24803617, compound
Reaction equation
[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([S:8]([NH:11][C:12]2[C:13]([C:19]3[N:23]([C:24]4[CH:28]=[CH:27][O:26][N:25]=4)[CH:22]=[N:21][N:20]=3)=[N:14][CH:15]=[C:16]([Cl:18])[CH:17]=2)(=[O:10])=[O:9])=[CH:4][C:3]=1[C:29]([F:32])([F:31])[F:30].C1C(=O)N([Br:40])C(=O)C1>C(Cl)(Cl)(Cl)Cl.C(Cl)Cl.C([O-])(O)=O.[Na+]>[Br:40][C:22]1[N:23]([C:24]2[CH:28]=[CH:27][O:26][N:25]=2)[C:19]([C:13]2[C:12]([NH:11][S:8]([C:5]3[CH:6]=[CH:7][C:2]([Cl:1])=[C:3]([C:29]([F:32])([F:31])[F:30])[CH:4]=3)(=[O:9])=[O:10])=[CH:17][C:16]([Cl:18])=[CH:15][N:14]=2)=[N:20][N:21]=1Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
4-Chloro-N-[5-chloro-2-(4-(isoxazol-3-yl)-4H-1,2,4-triazol-3-yl)pyridin-3-yl]-3-(trifluoromethyl)benzenesulfonamide (80 mg) in CCl4/DCM (3 mL/1 mL) was charged with NBS (30 mg). The resulting mixture was stirred at room temperature for 6 h. The reaction mixture was diluted with sat NaHCO3 and extracted EtOAc (50 mL×2), the combined organic layer was concentrated under reduced pressure. The residue was purified through automated normal-phase chromatography (10% to 100% gradient of EtOAc-Hexane), and followed by preparative HPLC (10% to 90% gradient of MeCN-water) and dried (Lyophilizer) to afford the title compound. 1H NMR (400 MHz, CDCl3) δ 11.6 (br, 1H), 8.60 (d, 1H), 8.46 (s, 1H), 8.27 (s, 1H), 8.19 (d, 1H), 7.98 (dd, 1H), 7.62 (d, 1H), 6.63 (d, 1H). MS (ES) [M+H]+ expected 584.0, found 584.0.
Workup
- extractionextracted EtOAc (50 mL×2)
- concentrationthe combined organic layer was concentrated under reduced pressure
- customThe residue was purified
- customdried (Lyophilizer)
Sources & evidence
- ORD record
- ord-120d58d594734b2a92d50ba1a25f16e3
- Source dataset
- uspto-grants-2010_03
- Patent number
- US07683176B2
Reaction notes
Loading…